Catherine Moukheibir's Net Worth
$847 Thousand
Who is Catherine Moukheibir?
Catherine Moukheibir does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IRONWOOD PHARMACEUTICALS INC, and MoonLake Immunotherapeutics.
SEC CIK
Catherine Moukheibir's CIK is 0001772130
Past Insider Trading and Trends
2023 was Catherine Moukheibir's most active year for acquiring shares with 6 total transactions. Catherine Moukheibir's most active month to acquire stocks was the month of May. 2024 was Catherine Moukheibir's most active year for disposing of shares, totalling 2 transactions. Catherine Moukheibir's most active month to dispose stocks was the month of May. 2022 saw Catherine Moukheibir paying a total of $0.00 for 68,037 shares, this is the most they've acquired in one year. In 2024 Catherine Moukheibir cashed out on 80,000 shares for a total of $517,693.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IRONWOOD PHARMACEUTICALS INC (IRWD) Snapshot price: $4.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +49.99% | 24.31K |
—
|
—
| 72.94K |
Jun 18
| |||
Form 4
| -62.19% | -80.00K |
$6.47 | -$517,693.50 | 48.63K |
Jun 6 - Jun 7
| |||
Form 4
| +1.24% | 1.57K |
—
|
—
| 128.63K |
Dec 15
| |||
Form 4
| +1.68% | 2.1K |
—
|
—
| 127.06K |
Sep 15
| |||
Form 4
| +21.78% | 22.35K |
—
|
—
| 124.96K |
Jun 20
| |||
Form 4
| +1.57% | 1.59K |
—
|
—
| 102.61K |
Jun 15
| |||
Form 4
| +1.69% | 1.68K |
—
|
—
| 101.03K |
Mar 15
| |||
Form 4
| +27.73% | 21.57K |
—
|
—
| 99.35K |
Jun 1
| |||
Form 4
| +1.92% | 1.47K |
—
|
—
| 77.78K |
Mar 15
| |||
Form 4
| +2.06% | 1.54K |
—
|
—
| 76.31K |
Dec 15
| |||
Form 4
| +1.97% | 1.45K |
—
|
—
| 74.77K |
Sep 15
| |||
Form 4
| +2.18% | 1.56K |
—
|
—
| 73.33K |
Jun 15
| |||
Form 4
| +46.47% | 22.77K |
—
|
—
| 71.76K |
Jun 2
| |||
Form 4
| +3.32% | 1.57K |
—
|
—
| 48.99K |
Mar 15
| |||
Form 4
| +84.51% | 21.72K |
—
|
—
| 47.42K |
Jun 3
| |||
Form 4
| +758.13% | 22.71K |
—
|
—
| 25.7K |
May 29
| |||
Form 4
|
∞
| 3K |
—
|
—
| 3K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MoonLake Immunotherapeutics (MLTX) Snapshot price: $46.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||